HLscience Co. Ltd (239610) - Total Assets
Based on the latest financial reports, HLscience Co. Ltd (239610) holds total assets worth ₩89.51 Billion KRW (≈ $60.66 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
HLscience Co. Ltd - Total Assets Trend (2014–2024)
This chart illustrates how HLscience Co. Ltd's total assets have evolved over time, based on quarterly financial data. Also see 239610 company net worth for the company's overall valuation and market capitalisation.
HLscience Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
HLscience Co. Ltd's total assets of ₩89.51 Billion consist of 33.9% current assets and 66.1% non-current assets. Review 239610 total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 16.6% |
| Accounts Receivable | ₩1.77 Billion | 1.8% |
| Inventory | ₩3.52 Billion | 3.6% |
| Property, Plant & Equipment | ₩42.86 Billion | 43.8% |
| Intangible Assets | ₩1.34 Billion | 1.4% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how HLscience Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See HLscience Co. Ltd stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: HLscience Co. Ltd's current assets represent 33.9% of total assets in 2024, a decrease from 41.2% in 2014.
- Cash Position: Cash and equivalents constituted 16.6% of total assets in 2024, up from 12.5% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 2.0% in 2014.
- Asset Diversification: The largest asset category is property, plant & equipment at 43.8% of total assets.
HLscience Co. Ltd Competitors by Total Assets
Key competitors of HLscience Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Yunnan Baiyao Group Co Ltd
SHE:000538
|
China | CN¥53.34 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Jiuzhitang Co Ltd
SHE:000989
|
China | CN¥5.73 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
HLscience Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 22.97 | 18.46 | 7.77 |
| Quick Ratio | 20.89 | 15.61 | 7.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩33.07 Billion | ₩33.31 Billion | ₩68.65 Billion |
HLscience Co. Ltd - Advanced Valuation Insights
This section examines the relationship between HLscience Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.47 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -7.7% |
| Total Assets | ₩97.78 Billion |
| Market Capitalization | $18.26 Million USD |
Valuation Analysis
Below Book Valuation: The market values HLscience Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: HLscience Co. Ltd's assets decreased by 7.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for HLscience Co. Ltd (2014–2024)
The table below shows the annual total assets of HLscience Co. Ltd from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩97.78 Billion ≈ $66.26 Million |
-7.73% |
| 2023-12-31 | ₩105.97 Billion ≈ $71.81 Million |
-2.62% |
| 2022-12-31 | ₩108.82 Billion ≈ $73.74 Million |
-7.68% |
| 2021-12-31 | ₩117.87 Billion ≈ $79.88 Million |
+10.09% |
| 2020-12-31 | ₩107.06 Billion ≈ $72.55 Million |
+13.38% |
| 2019-12-31 | ₩94.42 Billion ≈ $63.99 Million |
+32.22% |
| 2018-12-31 | ₩71.41 Billion ≈ $48.39 Million |
+23.68% |
| 2017-12-31 | ₩57.74 Billion ≈ $39.13 Million |
+5.78% |
| 2016-12-31 | ₩54.58 Billion ≈ $36.99 Million |
+213.85% |
| 2015-12-31 | ₩17.39 Billion ≈ $11.79 Million |
+25.25% |
| 2014-12-31 | ₩13.89 Billion ≈ $9.41 Million |
-- |
About HLscience Co. Ltd
HLscience Co., Ltd. manufactures and sells health functional foods in South Korea. The company offers organic barley grassjuice powder one day, queen's pomegranate jin, Super LuzieA+ Astaxanthin, Dr. Superkhan, HL-JOINT 100 for Joint & Cartilage Premium, Dr. Green Propolis, morosil diet fit, skin master secret, enerlinger vitamin D, PS300 formulated by doctor, Skin Master P-estro, and Dr. Prebiot… Read more